HROW
Companies
NASDAQ
Harrow Inc.
Health Care
$31.52
-$2.95 (-8.79%)
Price Chart
Overview
About HROW
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.
Market Cap
$642.9M
Volume
23.4M
Avg. Volume
19.7M
P/E Ratio
22.873787
Dividend Yield
0.00%
Employees
119.0
Company Information
Exchange
NASDAQ
Sector
Health Care
Industry
Drug Manufacturers - Specialty & Generic
Website
Risk & Correlation Analysis
Market Correlation
0.79
Moderate Correlation
Volatility
High (0.77)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, HROW shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$642.9M
Volume23.4M
P/E Ratio22.87
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 28, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025